Eylea® hd (aflibercept) injection 8 mg data presentations at aao reinforce efficacy and safety profile in wet age-related macular degeneration and diabetic macular edema

Long-term data and subgroup analyses from pivotal eylea hd clinical program highlight durability of visual improvements and consistent safety across extended dosing intervals and patient characteristics long-term data and subgroup analyses from pivotal eylea hd clinical program highlight durability of visual improvements and consistent safety across extended dosing intervals and patient characteristics
REGN Ratings Summary
REGN Quant Ranking